Hemolytic-uremic syndrome associated with neoadjuvant chemotherapy in the treatment of advanced cervical cancer (Q28323535)

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

2 November 2022

3

P J DiSaia

0 references

Michael L. Berman

6

object named as

M L Berman

0 references

author name string

G. Angiola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699855

2 November 2022

J. D. Bloss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699855

2 November 2022

A. S. Warner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699855

2 November 2022

A. Manetta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699855

full work available at URL

2 November 2022

language of work or name

English

0 references

publication date

November 1990

0 references

https://api.elsevier.com/content/article/PII:009082589090435N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

https://api.elsevier.com/content/article/PII:009082589090435N?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

2 November 2022

0 references

39

0 references

issue

2

0 references

page(s)

214-7

0 references

cites work

Advanced stage IIIB cancer of the cervix treatment by hyperthermia and radiation

3

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Neoadjuvant therapy for advanced squamous cell carcinoma of the cervix: cisplatin followed by radiation therapy--a pilot study of the Gynecologic Oncology Group

2 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

The treatment of advanced recurrent carcinoma of the uterine cervix with platinum based cytotoxic chemotherapy

2 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

A possible new trend in the management of the carcinoma of the cervix uteri

2 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Results of a phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix uteri

2 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor

2 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Simultaneous radiation and chemotherapy for advanced carcinoma of the cervix

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Hemolytic uremic syndrome and metastatic malignancy.

2 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Recurrent hemolytic uremic syndrome and metastatic malignancy

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy

2 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column

2 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy

2 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90435-N

2 November 2022

Identifiers

0 references